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Abstract
Background: There have been numerous efforts to improve and assure the quality of treatment
and follow-up of people with Type 2 diabetes (PT2D) in general practice. Facilitated by the
increasing usability and validity of guidelines, indicators and databases, feedback on diabetes care is
a promising tool in this aspect. Our goal was to assess the effect of feedback to general
practitioners (GPs) on the quality of care for PT2D based on the available literature.
Methods: Systematic review searches were conducted using October 2008 updates of Medline
(Pubmed), Cochrane library and Embase databases. Additional searches in reference lists and
related articles were conducted. Papers were included if published in English, performed as
randomized controlled trials, studying diabetes, having general practice as setting and using
feedback to GPs on diabetes care. The papers were assessed according to predefined criteria.
Results: Ten studies complied with the inclusion criteria. Feedback improved the care for PT2D,
particularly process outcomes such as foot exams, eye exams and Hba1c measurements. Clinical
outcomes like lowering of blood pressure, Hba1c and cholesterol levels were seen in few studies.
Many process and outcome measures did not improve, while none deteriorated. Meta analysis was
unfeasible due to heterogeneity of the studies included. Two studies used electronic feedback.
Conclusion: Based on this review, feedback seems a promising tool for quality improvement in
diabetes care, but more research is needed, especially of electronic feedback.
Background
In our efforts to improve and assure the quality of care in
general practice, information technology is becoming
increasingly used [1]. Quality improvement tools for dia-
betes, often delivered electronically, include general infor-
mation and clinical guidelines, feedback on the quality of
care as well as patient information letters. Furthermore,
many general practitioners (GPs) use electronic patient's
records. The use of information technology in general
practice is facilitated by the increasing numbers and valid-
ity of clinical databases [2]. These databases make it pos-
sible to extract accurate information in an easy and low
cost way.
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In 2006, a Cochrane review concluded that "Audit and
feedback can be effective in improving professional prac-
tice (...) the relative effectiveness of audit and feedback is
likely to be greater when baseline adherence to recom-
mended practice is low (...)[3].
Recent published figures [4] show that 88% of native
Danish PT2D had their Hba1c measured at least once dur-
ing year 2003; for eye examinations the figure was 33%
increasing to only 61% over a four year period. 70% of the
native Danish PT2Ds had an annual serum cholesterol
measurement. These figures show that there is room for
improvement when it comes to caring for PT2Ds.
Recent reviewing of prompting clinicians about preven-
tive care measures have revealed a modest consequence,
with cardiac care and smoking cessation reminders being
most effective [5]. The aim of this paper was to review the
available literature on the effect of feedback on diabetes
care in general practice, and more specifically whether
there was an effect of feedback to GPs on process and out-
come measures for the quality of care for PT2D and to
what extent electronic feedback had been investigated. We
define feedback as "any summary of clinical performance
of health care over a specified period of time". Electronic
feedback is defined in the same way but delivered to the
end user via computer [3].
Methods
A search was conducted using October 2008 updates of
Medline (Pubmed), Cochrane library and Embase data-
bases. Only English written papers were included in this
review. The searches were not time period limited
Separate searches were conducted on the following MeSH
and in-text terms:
#1: Type 2 Diabetes, #2: General Practice, #3: Family med-
icine, #4: Family medicin, #5: Family Practice, #6: Feed-
back, #7 Decision support, #8: Reminder system.
These searches were then combined into: #9: (#2 or #3 or
#4 or #5) and #10: (#6 or #7 or #8). Finally, all searches
were combined into #11: (#1 and #9 and #10).
The search and assessment strategies used in this review
were based on course material from the DIRAC course of
Systematic reviews and Meta Analysis held in Copenha-
gen in August 2007 [6]. However, as the aim was not to
perform a meta-analysis and a thorough rating of the evi-
dence, only one researcher did the searching and primary
assessments. First author (TLG) did all the searches and
assessing and discussed any doubts with the rest of the
research team. Further, all results were scrutinised by the
research group.
The search term "Type 2 Diabetes" was chosen above
"Diabetes Mellitus" to fulfil the aim of this review, which
does not consider "Type 1 Diabetes". Even though the
Mesh term "Type 2 Diabetes" is relatively new, it realised
papers published between 1994 and 2005. One unpub-
lished study was considered for inclusion, based on pub-
lished work concerning the methodology of the study.
However, correspondence with the research team running
the trial was inconclusive and left the study irrelevant for
reviewing. Reviews that appeared in the searches were
used in order to check the reference lists for includable
randomized trials. The term "reminder system" was
included as it was discovered that this term often covered
what we defined as feedback. To distinguish between
reminder system and feedback we assessed each of the
retrieved papers separately.
The reference lists of the papers retrieved were checked for
includable papers as were the "related articles" facility in
PubMed. An initial database search retrieved six papers
and a search of the related articles and reference list
included an additional eight papers. Ten of the14 papers
complied with the following inclusion criteria:
• Randomised trial
￿ Study concerning diabetes
￿ Study set in general practice
￿ Interventions aiming at using feedback to GPs on
diabetes care.
The remaining four articles were excluded because they
did not concern feedback.
Assessment
The included studies were assessed according to prede-
fined criteria:
￿ Aim of the study (How well did design cohere with
study aim)
￿ Method of evaluation (How well did methods of
analysis cohere with study design?)
￿ Format of feedback/intervention (Electronic or not)
￿ Effect measure divided into:
+ Process measures, i.e. are things done? Is, e.g.
HbA1c measured according to the study-based
guidelines?BMC Family Practice 2009, 10:30 http://www.biomedcentral.com/1471-2296/10/30
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+ Outcome measures, i.e. has the level improved?
Have, e.g. the HbA1c levels improved according to
the aims of the study-based guidelines?
￿ Effect of feedback
￿ Data collection
￿ Problems identified in randomization, sampling,
blinding and drop-out
Results
The ten papers presented ten different studies. Of these,
six were conducted in USA, one in New Zealand, one in
The Netherlands and two in Scandinavia. The papers were
published between 1994 and 2005, of these two before
2000. The duration of the trials varied between two
months and six years, with a median duration of 12
months.
Table 1 summarizes the studies on design, number of par-
ticipants, trial duration and data collection. The method
of evaluation and effect measures are summarized in
Table 2 and statistical significant effect measures are sum-
marized in Table 3.
Aim of the studies
All studies aimed at improving the GPs' adherence to the
diabetes guidelines in order to improve the care for PT2D.
All the studies leaned on existing guidelines or developed
guidelines as a part of the intervention.
Format of feedback (interventions)
Nine studies used feedback distributed to the GPs in
printed format [7-14] and two used electronic feedback
[14,15]. One study using electronic feedback also distrib-
uted the reports on paper [12]. Eight studies generated
patient specific feedback [7,9-12,14,15] while two gener-
ated aggregated feedback for specific practices or physi-
cians [8,16].
Study design used to evaluate feedback varied according
to whether the feedback was the single aim of evaluation,
or the feedback was only part of a larger intervention with
the aim of evaluating other means of quality improve-
ment as well. Six study groups concentrated only on feed-
back in their interventions [9,10,13-16]. Of these, one
added benchmarks to the feedback in one intervention
arm [16], and one let the patients fill in the feedback
reports in the GP's waiting room [13].
Three studies compared regular feedback to other inter-
ventions, or combined feedback with other means of sup-
port: One combined feedback with outreach visits [8]; one
compared feedback with face to face evaluation with an
endocrinologist [7]. One study compared feedback filled
in by patients in the waiting room and delivered in paper
format with a computer reminder consisting of a blinking
icon on the GP's computer screen [11].
One study categorised the intervention as multifaceted,
and feedback to the GPs was part of the intervention [12].
Effect measures
All studies used process measures that were part of routine
diabetes management, i.e. measuring blood glucose and
serum cholesterol. Some used composite outcomes such
as compliance rates, measuring the compliance of the GPs
to the diabetes guidelines, while others focused on spe-
cific process or outcome measures (Table 2).
One study differed from the others by using groups of
endpoints defined as: PT2D satisfaction (PS), Diabetes
specific quality of life (Dsql) and Depression severity
symptoms (Dss) evaluated by using validated question-
naires [13]. These endpoints were based on question-
naires and process measures combined.
Data collection
Data were collected via chart review [9,10,15,16], encoun-
ter forms filled in by the participating GPs [8,11], data-
bases [14], or by combining the methods [10,11]. In one
study, all included patients were examined by one data
collecting member of the research team [7].
Effect of feedback
One study showed no statistical, significant changes [10].
Nine papers reported a total of 23 statistically significant
positive changes [7-9,11-16]. Fifty one variables in nine
papers did not change statistically significantly. No nega-
tive changes were reported (See Table 3). The process
measure most often improved was foot examination.
Aggregated outcomes improved significantly in three tri-
als [9,13,14].
Long term effects
Our searches revealed 3 interventions which lasted more
than three years [7,12,16]. All three interventions showed
significant positive results. In one trial, the researchers
concentrated on process measures. They showed signifi-
cant results on foot examination, Hba1c measurement
and influenza vaccination [16]. The two other trials both
included effect measures, and both showed significant
improvements on Hba1c levels, serum cholesterol levels
and blood pressure levels [7,12]. One long term trial
included effect measures such as mortality, diabetic retin-
opathy, AMI, stroke, angina pectoris, claudicatio and
amputation, but did not manage to show significant
changes on any of these measures over a period of six
years.B
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) Table 1: Summary of intervention design, trial duration
Author/Country Intervention design Trial 
duration
No. patients 
(intervention/control)
No. doctors 
(intervention/control)
Data collection
Phillips [7]/USA. 2005 Clinicians were randomized to be controls or receive either 
computerized reminders, feedback on performance from 
specialized endocrinologist or both interventions. Feedback 
sessions with endocrinologist focused on individual provider 
actions or outcomes of specific patients.
3 years. 4138 
(3155 divided into 3 
groups/983)
345 (?/?) Research assistants 
encountered with all 
the patients to 
collect data.
Sequist [14]/USA. 2005 Clinics were randomized so that physicians received either 
evidence-based electronic reminders within their patients' 
electronic medical record or usual care. There were five 
reminders for diabetes care.
6 months 4549 (2924/3319). No 
drop out.
194 (92/102) Data collected using 
existing databases.
Frijling [8]/NL. 2002 The intervention group received feedback reports and support 
from a facilitator; the control group received no special attention.
23 months 2859 encounters (?/?) The 
exact number of patients 
is not reported.
124(62/62) Drop out: 2,4% GPs filled out 
encounter forms and 
questionnaires about 
patient 
characteristics.
Lobach [9]/USA. 1994 Clinicians were randomized to receive either a special encounter 
form with the computer-generated guideline recommendations or 
a standard encounter form.
6 months 359 (?/?). 58 (?/?).30 doctors 
included in analysis.
Researcher collected 
data by chart review.
Nilasena [10]/USA. 1995 Internal medicine residents were randomised to receive either 
computer-generated patient-specific reminders about the diabetes 
guidelines or a nonspecific report.
6 months 480 (?/?). 164 included in 
analysis 
(excluded: 66%)
35 (?/?) Researcher collected 
data by chart review.
Hetlevik [15]/N. 2000 Clinics were randomized to receive either electronic clinical 
reminders within the electronic patient records and reports on 
diabetes care in general or no special attention.
18 months 1034 (499/535) 53 (24/29) Data was collected 
in GPs records. A 
questionnaire was 
distributed among 
the participating GPs
Kenealy [11]/NZ. 2005 Four intervention arms: patient reminders, computer reminders, 
both reminders, and usual care. The patient reminder was a 
diabetes risk self-assessment sheet filled in by patients and given to 
the doctor during the consultation. The computer reminder was 
an icon that flashed only for patients considered eligible for 
diabetes screening. Clinics were units of randomization.
2 months 5628. (4756 divided in 3 
groups)/872)
112 (83/29). Drop out 
13,4%.
GPs answered on 
encounter forms 
whether or not they 
had screened for 
diabetes.
Kiefe [16]/USA. 2001 Physicians were assigned to either a multimodal improvement 
intervention, including chart review and physician-specific feedback 
or an identical intervention plus achievable benchmark feedback.
3 years 2978 (?/?) 70 (35/35) Data obtained from 
chart review by 
researchers
de Fine Olivarius[12]/DK. 
2001
Clinicians were randomized to either controls or structured care 
comprising of regular follow up and goal setting of specific patients. 
This was supported by prompting of doctors, clinical guidelines, 
feedback and continuing medical education.
6 years 944 (459/415) 484 (?/?). Drop out: 40,5% 
in both control and 
intervention group.
Data collected 
through GPs, 
through eye doctors, 
via laboratory 
databases and via 
questionnaires to 
patients.
Glasgow [13]/USA. 2004 Physicians were randomised to receive either a CD ROM-assisted 
diabetes care enhancement program were patients were invited to 
complete the computerized Diabetes Priority Program touch 
screen assessment and feedback procedure, or to receive no 
special attention.
6 months 886 (469/417) 52 (24/28) Data primarily 
collected via 
patients. Some data 
collected in 
laboratory database.
? = Information unavailable in paperBMC Family Practice 2009, 10:30 http://www.biomedcentral.com/1471-2296/10/30
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Methodological problems identified
In two studies, the participating GPs all worked in the
same health facility [7,10]. This may have produced a
spill-over effect. There was a profound sampling variation
in the included studies, for example: One study group
chose to set up inclusion criteria for the GPs' participation
in the study [9]. Another study group invited the partici-
pating GPs through ads in newspapers [8]. In one study,
only 5% of the invited GPs participated in the study [13].
This variation in sampling makes comparison between
the included studies difficult and meta-analysis irrelevant.
All studies were un-blinded to participating doctors, as
allocation concealment was not possible. Some attempts
of blinding were made in one study [17]. However, three
study groups did anticipate the problem of contamination
between intervention and control groups. One performed
statistical analysis to investigate the size of the problem,
which was seemingly insignificant [7]. Another study
group argued against contamination due to lack of blind-
ing in the study, based on recorded differences between
control an intervention group, but without performing
any statistical analysis of the size of the problem [8].
Lastly, one study group, as mentioned above, attempted
blinding. However, the researchers themselves argue in
the paper that the blinding was not extensive enough.
Electronic feedback
Two trials complied with the definition of using electronic
feedback [14,15]. Both trials obtained statistical signifi-
cant effects on single measurements: Cholesterol meas-
urement and blood pressure level, respectively. In
addition, one of the trials demonstrated a statistical signif-
icant improvement of the compliance rate (Table 3).
Discussion
Main findings
This review demonstrates that it seems possible to
improve the quality of diabetes care using feedback to the
GPs. Significant positive changes are primarily seen on
process, but also on outcome of Type 2 diabetes care. In
many studies, large numbers of effect measures showed
no significant change, but no study groups report deterio-
ration in effect measures. In table 2 effect measures which
showed significant positive changes are marked. All of the
included studies leaned on national diabetes guidelines or
developed diabetes guidelines for good control and care
within the study.
Implications of findings
The findings of this review indicate that feedback could be
a valuable asset in quality improvement efforts. In the
2006 Cochrane Review referred to earlier in this paper, it
was stated that "(...) the relative effectiveness of audit and
feedback is likely to be greater when baseline adherence to
recommended practice is low (...)" [3]. The results of this
review support that statement to a certain extent: Among
the endpoints reviewed, three endpoints showed signifi-
cant improvement in more than one trial, namely num-
bers of foot examination made and the mean level of
Hba1c and blood pressure. Foot examination is tradition-
ally an endpoint with low guideline adherence. Mean
level of Hba1c and blood pressure are influenced by life
style changes and medication alterations, and so is very
dependent on a strong commitment in the patient to alter
their life style. Often, the strong dependency on life style
changes can be unappealing to the doctors, because moti-
vating the patient for life style changes is a difficult path to
embark on [18].
Strengths and weaknesses
The strength of this review is the specific aim limiting the
searches to include only feedback trials on diabetes care in
general practice. Ideally, this would optimise the homoge-
neity of the studies and strengthen the conclusions of the
review.
One weakness was the risk of missing important trials.
Papers written in other languages than English were
excluded and it has been reported that such exclusion of
trials in systematic reviews increases the likelihood of sys-
tematic errors and reduces precision [19].
It was not possible to perform meta-analysis on the find-
ings due to heterogeneity of the studies included: The
designs and methods of feedback were too inconsistent
and the endpoints measured and the duration of the trials
varied too much. The aim of all studies included however,
was to improve diabetes care in general practice, accord-
ing to the relevant guidelines. This common goal, paired
with the delivering of feedback to GPs in all the studies
included makes it relevant to draw conclusions based on
this review.
Delivering feedback
Clinicians have limited time to concentrate on quality
improvement in daily practice which is why efforts to
improve and sustain quality should be made as easily
available and useable as possible [20]. Using computers is
generally considered to be a positive thing saving time to
the daily routines for GPs [21,22]. Considering this, it is
striking that so few trials have tested electronic feedback
on diabetes care in general practice.
Evaluating feedback
An important point when evaluating research within the
field of quality improvement is choosing the relevant
effect measures [18]. The studies included in this review
were not consistent in choosing effect measures.BMC Family Practice 2009, 10:30 http://www.biomedcentral.com/1471-2296/10/30
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Table 2: Evaluation methods and effect measures used in the ten studies
Evaluation method Effect measures
Study Proces Outcome
Phillips [7] Pre- and post intervention mean group differences on patients in 
intervention vs. control groups.
†Mean Hba1c.
Mean Ldl
Cholesterol.
Blood pressure.
Sequist [14] Both summary and individual composite endpoints †Cholesterol measured, 
Hba1c measured.
Eye exam.
ACE inh if hypertension.
†Odds of receiving 
recommended diabetes 
care *
Summary endpoint: diabetes reminders resulting in action/diabetes 
reminders in total
Individual endpoints: No. of appropriate diabetes health services 
received by pt/total no. of diabetes health services pt
Frijling [8] Mean compliance rate for each performance indicator at baseline and 
the mean change from baseline.
†Foot exam.
†Eye exam.
BMI.
Medication.
Measured blood press. Anti 
diabetic treatment. 
Scheduled next appointment
Lobach [9] Mean compliance rate for each performance indicator at baseline and 
the mean change from baseline. Composite outcome of all 
performance indicators at baseline and the mean change from 
baseline.
†Physical exam
†Urine protein measured.
†Cholesterol measured. Eye 
exam.
Influenza vac. Pneumococ 
vac.
Foot exam. Hba1c 
measured.
†Median level of 
compliance *
†Median adherence rate of 
the clinicians *
Nilasena [10] Mean compliance rate for each performance indicator at baseline and 
the mean change from baseline.
Foot exam., physical exam.
Hba1c measured.
Urine protein measured. 
Cholesterol measured. Eye 
exam.
Influenza vac. Pneumococ 
vac.
Hetlevik [15] Mean group differences in 
fractions of patients without 
registrations (process evaluation).
Mean group differences in 
variables 
(patient outcome evaluation)
Registered smoking habits.
BMI.
Blood pressure measured.
Hba1c measured. 
Cholesterol measured.
†Blood pressure.
Number of smokers.
BMI.
Mean Hba1c.
Mean cholesterol.
Kenealy [11] Was/not tested for blood glucose if eligible. †Blood glucose measured
Kiefe [16] Proportional changes in the receiving of guideline specific diabetic 
services.
†Influenza vac.
†Foot exam.
†Hba1c measured, 
cholesterol measured. 
Triglycerides measured
de Fine 
Olivarius [12]
Pre- and post intervention mean group differences on patients in 
intervention vs. control groups.
Measurement of blood 
glucose-
Measurement of Hba1c.
Measurement of blood 
pressure.
Measurement of cholesterol.
Measurement of 
triglycerides
†Level of plasma glucose.
†Level of Hba1c.
†Level of blood pressure. 
†Cholesterol Mortality.
Diabetic retinopathy.
AMI. Stroke.
Angina pectoris. 
Claudicatio,
Amputation.
Glasgow [13] Effect of system evaluated on 2 primary outcomes: number of 
recommended laboratory screenings and recommended patient-
centred care activities completed. Secondary outcomes were 
evaluated using the Problem Areas in Diabetes scale and the Patient 
Health Questionnaire.
†Foot exams.
†Nutrition counselling Blood 
pressure measured.
Eye exam.
Foot exam.
Micro albumin.
†No of recommended lab 
assays *
†Patient-centred aspects 
of diabetes care received *
† = Significant positive changes.
* Composite outcomeBMC Family Practice 2009, 10:30 http://www.biomedcentral.com/1471-2296/10/30
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Another issue is whether the changes detected in the effect
measures are actually attributable to feedback. In this
paper we included one obvious multifaceted intervention
[12]. While multifaceted interventions certainly have their
place in investigating quality improvement in diabetic
care, it can be difficult to know exactly which efforts made
the difference. We are aware that attributing the signifi-
cant changes in the care of the PT2D in the included mul-
tifaceted intervention solely to the efforts of providing
feedback to the GPs probably is an over-interpretation.
However, the effort of providing GPs with continuous
feedback was made, and therefore the intervention should
be considered in this review.
In this study we have limited our search to randomized
controlled trials (RCTs). This approach is debatable. One
could argue that, while RCTs are often referred to as the
gold standard of trial designs, it provides a one-shot effect,
which often covers a short time frame of the patients med-
ical history. It is evident, when researching within the field
of chronic disease management, that long term effects of
interventions are very relevant. However, follow-up over
time and without specific interventions demonstrates
huge improvements in diabetic care [23]. Thus, it is diffi-
cult in non-RCTs to be sure that the improvement in care
is due to the specific intervention applied. Within the field
of feedback on diabetes care to general practitioners, non-
RCT long term effect research has revealed effects on proc-
ess, outcome and the overall provision of diabetes care
[24,25]. Even though these studies have not been
included in this review due to design choices made, the
results still relevantly support the conclusion that feed-
back on diabetes care to general practitioners can lead to
better quality of care, and that this improvement of care
could possibly be long term.
Conclusion
We found that disease specific feedback to GPs has an
effect on diabetes care in General Practice. Pointing out
which effect measures that are mostly affected by the
interventions proved difficult.
Even though feedback seems a promising tool for quality
improvement, it was only possible to identify ten very het-
erogeneous studies that evaluated feedback to GPs on dia-
betes care in randomized, controlled trials. Only two trials
Table 3: Effect measures in trials with significant changes
Measure Author Effect
Proces measures (pm) (no. of trials in which pm was included)
Foot examination Kiefe [16] OR 1,33; 95%CI 1,05–1,69
Glasgow [13] RR 4,38; 95%CI 2,42–7,91; boc
Frijling [8] OR 1,68; 95%CI 1,19–2,39
Hba1c measurement Kiefe [16] OR 1,33; 95%CI 1,04–1,69
Eye examination Frijling [8] OR 1,52; 95%CI 1,07–2,16.
Glasgow [13] RR 1,79; 95%CI 1,20–2,68; boc
Influenza vaccination Kiefe [16] OR 1,57; 95%CI 1,26–1,96
Cholesterol measurement Lobach [9] duc, significant positive changes reported in text
Sequist*[14] HR 1,41; 95%CI 1,15–1,72
Blood glucose measurement Kenealy [11] Pt reminders OR 1,72; 95%CI 1,21–2,43
Kenealy [11] Computer reminders OR 2,55; 95%CI 1,68–3,88
Kenealy [11] Both reminders OR 1,69; 95%CI 1,11–2,59
Dietary advice Glasgow [13] p < 0,001;duc
Micro albumin measurement Lobach [9] duc, significant positive changes reported in text
Glasgow [13] RR 3,97; 95%CI 2,22–7,10; boc
Outcome measures (OM) (No. of trials in which OM was included)
Level of blood pressure De fine Olivarius [12] Δ-5 mmHg; 95%CI -7,6 to -2,4
Hetlevik* [15] Δ-2,3 mmHg; 95%CI -3,8 to -0,8
Phillips [7] OR 1,19; 95%CI 1,07–1,32
Level of Hba1c. Phillips [7] OR 1,18; 95%CI 1,03–1,34
De fine Olivarius [12] Δ-0,056%; 95%CI -0,081% to -0,031%
Level of cholesterol. De fine Olivarius [12] Δ-0,15 mmol/l; 95%CI -0,29 to -0,02
Aggregated measures (AM) (No. of trials in which AM was included)
Odds of receiving recommended care Sequist*[14] OR 1,30; 95%CI 1,01–1,67
Compliance rate Lobach [9] 32% vs. 15,6% (p = 0,02*), duc
Number of recommended lab assays Glasgow [13] F = 9,90, p < 0,001; duc
Patient Sataibisfaction Glasgow [13] F = 25,2, p < 0,001;duc
boc = Based on own calculations on data extracted from paper. duc = Data unavailable for further calculations. OR = Odds ratio. HR = Hazard 
ratio. RR = Relative risk. * = Electronic feedbackBMC Family Practice 2009, 10:30 http://www.biomedcentral.com/1471-2296/10/30
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evaluated electronic feedback in randomized trials and it
was not possible to quantify the added effect of electronic
feedback. Therefore, more research of this area is required.
Abbreviations
GP: General practitioner; PT2D: People with type 2-diabe-
tes; Boc: Based on own calculations on data extracted from
paper; Duc: Data unavailable for further calculations; OR:
Odds ratio; HR: Hazard ratio; Inh: inhibitor; Vac: vaccina-
tion; Exam: Examination.
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